Titelia

Funds holding Guizhou Xinbang Pharmaceutical Co Ltd

ISIN CNE100000NG5 · China · LEI 300300V0VT8TMAY8LY93

Fund holders
18
Of which ETFs
6 12 other funds
Value held
3.9M $
FundSharesValueWeight in fund
VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND VANGUARD STAR FUNDS 2,213,8001.1M $0.00 %as of Apr 30, 2026 ↗
VANGUARD EMERGING MARKETS STOCK INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS 1,609,931796.4K $0.00 %as of Apr 30, 2026 ↗
EMERGING MARKETS CORE EQUITY 2 PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC 1,071,897530.3K $0.00 %as of Apr 30, 2026 ↗
State Street(R) SPDR(R) Portfolio Emerging Markets ETF SPDR INDEX SHARES FUNDS 628,700298.6K $0.00 %as of Mar 31, 2026 ↗
VANGUARD FTSE ALL-WORLD EX-US SMALL-CAP INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS 598,100295.9K $0.00 %as of Apr 30, 2026 ↗
VANGUARD TOTAL WORLD STOCK INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS 376,400186.2K $0.00 %as of Apr 30, 2026 ↗
THE EMERGING MARKETS SMALL CAP SERIES DFA INVESTMENT TRUST CO 352,600174.4K $0.00 %as of Apr 30, 2026 ↗
Dimensional Emerging Markets Core Equity 2 ETF Dimensional ETF Trust 290,200143.1K $0.00 %as of Apr 30, 2026 ↗
DIMENSIONAL EMERGING MARKETS VALUE FUND DIMENSIONAL EMERGING MARKETS VALUE FUND 216,300107K $0.00 %as of Apr 30, 2026 ↗
Dimensional Emerging Core Equity Market ETF Dimensional ETF Trust 123,60061K $0.00 %as of Apr 30, 2026 ↗
Dimensional World ex. U.S. Core Equity 2 ETF Dimensional ETF Trust 108,70053.6K $0.00 %as of Apr 30, 2026 ↗
Dimensional Emerging Markets Value ETF Dimensional ETF Trust 99,50049.1K $0.00 %as of Apr 30, 2026 ↗
World ex U.S. Core Equity Portfolio DFA INVESTMENT DIMENSIONS GROUP INC 72,40035.8K $0.00 %as of Apr 30, 2026 ↗
Emerging Markets Sustainability Core 1 Portfolio DFA INVESTMENT DIMENSIONS GROUP INC 62,50030.9K $0.00 %as of Apr 30, 2026 ↗
World ex U.S. Targeted Value Portfolio DFA INVESTMENT DIMENSIONS GROUP INC 48,10023.8K $0.00 %as of Apr 30, 2026 ↗
Emerging Markets Targeted Value Portfolio DFA INVESTMENT DIMENSIONS GROUP INC 45,80022.7K $0.01 %as of Apr 30, 2026 ↗
SA Emerging Markets Value Fund SA FUNDS INVESTMENT TRUST 32,40015.4K $0.01 %as of Mar 31, 2026 ↗
Dimensional Emerging Markets Sustainability Core 1 ETF Dimensional ETF Trust 7,2003.6K $0.00 %as of Apr 30, 2026 ↗

Download this table: CSV, JSON

Report an error

The funds most exposed to it

The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.

FundWeight in fund
SA Emerging Markets Value Fund SA FUNDS INVESTMENT TRUST 0.01 %as of Mar 31, 2026 ↗
Emerging Markets Targeted Value Portfolio DFA INVESTMENT DIMENSIONS GROUP INC 0.01 %as of Apr 30, 2026 ↗
THE EMERGING MARKETS SMALL CAP SERIES DFA INVESTMENT TRUST CO 0.00 %as of Apr 30, 2026 ↗
Dimensional Emerging Markets Value ETF Dimensional ETF Trust 0.00 %as of Apr 30, 2026 ↗
World ex U.S. Targeted Value Portfolio DFA INVESTMENT DIMENSIONS GROUP INC 0.00 %as of Apr 30, 2026 ↗
Emerging Markets Sustainability Core 1 Portfolio DFA INVESTMENT DIMENSIONS GROUP INC 0.00 %as of Apr 30, 2026 ↗
VANGUARD FTSE ALL-WORLD EX-US SMALL-CAP INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS 0.00 %as of Apr 30, 2026 ↗
State Street(R) SPDR(R) Portfolio Emerging Markets ETF SPDR INDEX SHARES FUNDS 0.00 %as of Mar 31, 2026 ↗
Dimensional Emerging Markets Core Equity 2 ETF Dimensional ETF Trust 0.00 %as of Apr 30, 2026 ↗
EMERGING MARKETS CORE EQUITY 2 PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC 0.00 %as of Apr 30, 2026 ↗

Quarter after quarter

Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.

QuarterHoldersChangeSharesChange
2026Q218+17,958,128-0.6 %
2026Q11708,005,128+1.1 %
2025Q41707,917,628+0.4 %
2025Q31707,887,328-2.1 %
2025Q21708,060,328-5.3 %
2025Q11708,508,328+13.2 %
2024Q417+17,515,228+1.6 %
2024Q316-47,396,428-2.5 %
2024Q220+47,583,428+133.8 %
2024Q116-33,243,397-56.0 %
2023Q4197,376,328
Cite this page

Titelia. "Funds holding Guizhou Xinbang Pharmaceutical Co Ltd". https://titelia.com/en/stocks/guizhou-xinbang-pharmaceutical-co-ltd-CNE100000NG5